When the Genome Institute of Singapore (GIS) was established in 2000, the science of genomics was still in its infancy. Since then, genomics has proved its relevance to all aspects of biology and medicine. It is now possible to sequence entire populations and communities, resolve organs at the single-cell level, and develop treatments guided by genomic data. We are now able to edit genomes at will, synthesise chromosomes, and perform complex experiments in silico by harnessing the ever-growing reservoir of public-access data.
Importantly, while much has been done, much remains to be discovered as our knowledge of genomes, both human and non-human, remains incomplete. Through it all, GIS has maintained its leadership and relevance in genomic science by focusing on its three core strengths – asking the right biological questions, applying and developing cutting-edge technology platforms, and embracing multi-disciplinary team science. These core strengths have served us well, and will continue to do so in the future, as we work with our partners in the local and international ecosystem, including fellow Research Institutes, hospitals, universities, public agencies, and industry partners.
Our ultimate vision is for genomics to improve the lives of every Singaporean, in one way or another. I am excited to lead GIS in charting new frontiers in genomic science, and I invite you to join us on this exciting journey.
The Genome Institute of Singapore (GIS) is a national initiative with a global vision that seeks to use genomic sciences to Achieve Extra Ordinary Improvements in Human Health and Public Prosperity.
As a centre for genomic discovery, the GIS will pursue the integration of technology, genetics and biology towards Academic, Economic and Societal Impact.